Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3117-3117
Keyword(s):
Phase I
◽
2005 ◽
Vol 63
(4)
◽
pp. 1276
◽
2014 ◽
Vol 146
(1)
◽
pp. 145-152
◽
2010 ◽
Vol 26
(5)
◽
pp. 514-521
◽
2008 ◽
Vol 72
(1)
◽
pp. S183-S184
2005 ◽
Vol 61
(4)
◽
pp. 1045-1053
◽